BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 19844102)

  • 1. Physician-determined worsening heart failure: a novel definition for early worsening heart failure in patients hospitalized for acute heart failure--association with signs and symptoms, hospitalization duration, and 60-day outcomes.
    Cotter G; Metra M; Weatherley BD; Dittrich HC; Massie BM; Ponikowski P; Bloomfield DM; O'Connor CM
    Cardiology; 2010; 115(1):29-36. PubMed ID: 19844102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing and Causes of Readmission After Acute Heart Failure Hospitalization-Insights From the Heart Failure Network Trials.
    Vader JM; LaRue SJ; Stevens SR; Mentz RJ; DeVore AD; Lala A; Groarke JD; AbouEzzeddine OF; Dunlay SM; Grodin JL; Dávila-Román VG; de Las Fuentes L
    J Card Fail; 2016 Nov; 22(11):875-883. PubMed ID: 27133201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Torsemide vs Furosemide Among Patients With New-Onset vs Worsening Chronic Heart Failure: A Substudy of the TRANSFORM-HF Randomized Clinical Trial.
    Krim SR; Anand S; Greene SJ; Chen A; Wojdyla D; Vilaro J; Haught H; Herre JM; Eisenstein EL; Anstrom KJ; Pitt B; Velazquez EJ; Mentz RJ
    JAMA Cardiol; 2024 Feb; 9(2):182-188. PubMed ID: 37955908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remote management of worsening heart failure to avoid hospitalization in a real-world setting.
    Ploux S; Strik M; Ramirez FD; Buliard S; Chauvel R; Dos Santos P; Haïssaguerre M; Jobbé-Duval A; Picard F; Riocreux C; Eschalier R; Bordachar P
    ESC Heart Fail; 2023 Dec; 10(6):3637-3645. PubMed ID: 37797957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organ perfusion pressure at admission and clinical outcomes in patients hospitalized for acute heart failure.
    Bocchino PP; Cingolani M; Frea S; Angelini F; Gallone G; Garatti L; Sacco A; Raineri C; Pidello S; Morici N; De Ferrari GM
    Eur Heart J Acute Cardiovasc Care; 2024 Feb; 13(2):215-224. PubMed ID: 37883706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of cardiac worsening through to cardiogenic shock in patients with acute heart failure.
    Beer BN; Kellner C; Sundermeyer J; Besch L; Dettling A; Kirchhof P; Blankenberg S; Magnussen C; Schrage B
    ESC Heart Fail; 2024 Apr; ():. PubMed ID: 38632837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Challenges in Heart Failure with Reduced Ejection Fraction: Managing Worsening Events.
    Lavalle C; Di Lullo L; Jabbour JP; Palombi M; Trivigno S; Mariani MV; Summaria F; Severino P; Badagliacca R; Miraldi F; Bellasi A; Vizza CD
    J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-hospital worsening heart failure: a clinically relevant endpoint?
    Clark AL; Cherif M; McDonagh TA; Squire IB
    ESC Heart Fail; 2018 Feb; 5(1):9-18. PubMed ID: 29385659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Length of hospital stay and associated factors among heart failure patients admitted to the University Hospital in Northwest Ethiopia.
    Tigabe Tekle M; Bekalu AF; Tefera YG
    PLoS One; 2022; 17(7):e0270809. PubMed ID: 35867684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticosteroid burst therapy in patients with acute heart failure: Design of the CORTAHF pilot study.
    Cotter G; Davison B; Freund Y; Mebazaa A; Voors A; Edwards C; Novosadova M; Takagi K; Hayrapetyan H; Mshetsyan A; Mayranush D; Cohen-Solal A; Ter Maaten JM; Biegus J; Ponikowski P; Filippatos G; Chioncel O; Pagnesi M; Simon T; Metra M; Mann DL
    ESC Heart Fail; 2024 Jun; ():. PubMed ID: 38943232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The different risk of new-onset, chronic, worsening, and advanced heart failure: A systematic review and meta-regression analysis.
    Shakoor A; Abou Kamar S; Malgie J; Kardys I; Schaap J; de Boer RA; van Mieghem NM; van der Boon RMA; Brugts JJ
    Eur J Heart Fail; 2024 Feb; 26(2):216-229. PubMed ID: 37823229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-Based Differences in the Epidemiology, Clinical Characteristics, and Outcomes Associated with Worsening Heart Failure Events in a Learning Health System.
    Leung CJ; Bhatt AS; Go AS; Parikh RV; Garcia EA; LE KC; Low D; Allen AR; Fitzpatrick JK; Adatya S; Sax DR; Goyal P; Varshney AS; Sandhu AT; Gustafson SE; Ambrosy AP
    J Card Fail; 2024 Apr; ():. PubMed ID: 38697466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Worsening heart failure: a concept in evolution.
    Puthenpura M; Wilcox J; Tang WHW
    Curr Opin Cardiol; 2024 Mar; 39(2):119-127. PubMed ID: 38116785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Time is prognosis' in heart failure: time-to-treatment initiation as a modifiable risk factor.
    Abdin A; Anker SD; Butler J; Coats AJS; Kindermann I; Lainscak M; Lund LH; Metra M; Mullens W; Rosano G; Slawik J; Wintrich J; Böhm M
    ESC Heart Fail; 2021 Dec; 8(6):4444-4453. PubMed ID: 34655282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying natural language processing to identify emergency department and observation encounters for worsening heart failure.
    Hamilton SA; Ambrosy AP; Parikh RV; Tan TC; Fitzpatrick JK; Avula HR; Sandhu AT; Ku IA; Go AS; Sax D; Bhatt AS
    ESC Heart Fail; 2024 May; ():. PubMed ID: 38741373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal plasma ceramides refine high-risk patients with worsening heart failure.
    Ren L; Li F; Tan X; Fan Y; Ke B; Zhang Y; Jiang H; Jia L; Wang Y; Du J
    Front Cardiovasc Med; 2023; 10():1185595. PubMed ID: 37456812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WHF Roadmap on Secondary Prevention of CVD.
    Wood DA
    Glob Heart; 2024; 19(1):9. PubMed ID: 38273997
    [No Abstract]   [Full Text] [Related]  

  • 18. Sex Differences in Worsening Heart Failure: Learning From Real-world Evidence.
    Saldarriaga C; García-Arango M; Valentina López L; Contreras J
    J Card Fail; 2024 May; ():. PubMed ID: 38823433
    [No Abstract]   [Full Text] [Related]  

  • 19. Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial.
    Teerlink JR; Cotter G; Davison BA; Felker GM; Filippatos G; Greenberg BH; Ponikowski P; Unemori E; Voors AA; Adams KF; Dorobantu MI; Grinfeld LR; Jondeau G; Marmor A; Masip J; Pang PS; Werdan K; Teichman SL; Trapani A; Bush CA; Saini R; Schumacher C; Severin TM; Metra M;
    Lancet; 2013 Jan; 381(9860):29-39. PubMed ID: 23141816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dyspnoea and worsening heart failure in patients with acute heart failure: results from the Pre-RELAX-AHF study.
    Metra M; Teerlink JR; Felker GM; Greenberg BH; Filippatos G; Ponikowski P; Teichman SL; Unemori E; Voors AA; Weatherley BD; Cotter G
    Eur J Heart Fail; 2010 Oct; 12(10):1130-9. PubMed ID: 20732868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.